Effects of A-192621.1, a specific endothelin-B antagonist, on intrarenal hemodynamic responses to endothelin-1

Citation
S. Brodsky et al., Effects of A-192621.1, a specific endothelin-B antagonist, on intrarenal hemodynamic responses to endothelin-1, J CARDIO PH, 36, 2000, pp. S311-S313
Citations number
11
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
ISSN journal
01602446 → ACNP
Volume
36
Year of publication
2000
Supplement
1
Pages
S311 - S313
Database
ISI
SICI code
0160-2446(2000)36:<S311:EOAASE>2.0.ZU;2-I
Abstract
The present study examined the effects of A-192621.1, a highly selective en dothelin-B- (ETB) receptor antagonist, on the renal hemodynamic and systemi c actions of endothelin-1 (ET-1). Intravenous injection of ET-1 (1.0 nmol/k g) into anesthetized rats produced a sustained decrease in renal blood flow (assessed by ultrasonic flowmeter) and a significant increase in renal vas cular resistance, as well as an increase in mean arterial pressure. These c hanges were significantly augmented by pretreatment with A-192621.1 (3.0 mg /kg/h). Analysis of intrarenal blood flow by laser-Doppler flowmeter reveal ed that ET-1 caused a marked and sustained decrease in cortical blood flow, associated with a transient increase in medullary blood flow. The reductio n in cortical blood flow in response to ET-1 was further enhanced by pretre atment with A-192621.1, whereas the ET-1-induced medullary vasodilatation w as completely abolished and reversed into a vasoconstrictor response. These findings suggest that the ETB-receptors mediate the systemic and renal vas odilatory actions of ET-1 in the rat, and that their activation may serve a s a physiological counterbalance that modulates ET-1-induced vasoconstricti on.